B cells in the aging immune system: Time to consider B-1 cells

Annals of the New York Academy of Sciences

Volumn 1362, Issue 1, 2015, Pages 176-187

  Holodick, Nichol E ^a   Rothstein, Thomas L ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Aging; B cells; B 1 cells; Senescence

Indexed keywords

IMMUNOGLOBULIN M; SECRETORY IGM;

AGING; ARTICLE; B LYMPHOCYTE; CELL MATURATION; HEMATOPOIETIC STEM CELL; IMMUNE SYSTEM; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; NONHUMAN; SENESCENCE; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; B-LYMPHOCYTE SUBSETS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; IMMUNOGLOBULIN M;

EID: 84959521201     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12825     Document Type: Article

References (92)

1. Centers for Disease Control and Prevention 2013. The State of Aging and Health in America 2013. http://www.cdc.gov/aging/pdf/state-aging-health-in-america-2013.pdf. Accessed July 7, 2015.
2. Centers for Disease Control and Prevention 1997. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 46: 1-24.
3. Centers for Disease Control and Prevention. 2010. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, provisional-2009. http://www.cdc.gov/abcs/reports-findings/survreports/spneu09.pdf. Accessed July 7, 2015.
4. Iyer, A.S. et al. 2015. Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic. Exp. Rev. Vac. 14: 85-97.
5. WHO 2014. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index4.html. Accessed July 7, 2015.
6. Lusis, A.J. 2000. Atherosclerosis. Nature 407: 233-241.
7. Binder, C.J. & G.J. Silverman. 2005. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin. Immunopathol. 26: 385-404.
8. Kyaw, T. et al. 2011. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109: 830-840.
9. Chen, X. & P.E. Jensen. 2008. The role of B lymphocytes as antigen-presenting cells. Arch. Immunol. Ther. Exp. 56: 77-83.
10. Scholz, J.L. et al. 2013. A comparative review of aging and B cell function in mice and humans. Curr. Opin. Immunol. 25: 504-510.
11. Spangrude, G.J. et al. 1991. Mouse hematopoietic stem cells. Blood 78: 1395-1402.
12. Lam, K.P. et al. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90: 1073-1083.
13. Li, Y.S. et al. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178: 951-960.
14. Li, Y.S. et al. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5: 527-535.
15. Desiderio, S.V. et al. 1984. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311: 752-755.
16. Rolink, A. & F. Melchers. 1993. B lymphopoiesis in the mouse. Adv. Immunol. 53: 123-156.
17. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
18. Montecino-Rodriguez, E. et al. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7: 293-301.
19. Geiger, H. et al. 2013. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13: 376-389.
20. Linton, P.J. & K. Dorshkind. 2004. Age-related changes in lymphocyte development and function. Nat. Immunol. 5: 133-139.
21. Morrison, S.J. et al. 1996. The aging of hematopoietic stem cells. Nat. Med. 2: 1011-1016.
22. Sudo, K. et al. 2000. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192: 1273-1280.
23. Miller, J.P. & Allman, D. 2005. Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin. Immunol. 17: 321-329.
24. Shimazu, T. et al. 2012. CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential. Blood 119: 4889-4897.
25. Welner, R.S. et al. 2008. Evolving views on the genealogy of B cells. Nat. Rev. Immunol. 8: 95-106.
26. de Pooter, R.F. & B.L. Kee. 2010. E proteins and the regulation of early lymphocyte development. Immunol. Rev. 238: 93-109.
27. Lescale, C. et al. 2010. Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age. Aging Cell 9: 410-419.
28. Miller, J.P. & Allman, D. 2003. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J. Immunol. 171: 2326-2330.
29. Riley, R.L. et al. 1991. B cell precursors are decreased in senescent BALB/c mice, but retain normal mitotic activity in vivo and in vitro. Clin. Immunol. Immunopathol. 59: 301-313.
30. Frasca, D. et al. 2008. Mechanisms for decreased function of B cells in aged mice and humans. J. Immunol. 180: 2741-2746.
31. Sherwood, E.M. et al. 2000. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins. Mech. Ageing Dev. 118: 45-59.
32. Jensen, C.T. et al. 2008. FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. Blood 112: 2297-2304.
33. Lin, H. & R. Grosschedl. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267.
34. Stephan, R.P. et al. 1997. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J. Immunol. 158: 1598-1609.
35. Labrie, J.E., 3rd et al. 2004. Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J. Exp. Med. 200: 411-423.
36. Ergen, A.V. et al. 2012. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 119: 2500-2509.
37. Jung, D. et al. 2006. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 24: 541-570.
38. Van der Put, E. et al. 2004. Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J. Immunol. 173: 818-827.
39. Mikkola, I. et al. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science 297: 110-113.
40. Sigvardsson, M. et al. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7: 25-36.
41. Riley, R.L. 2013. Impaired B lymphopoiesis in old age: a role for inflammatory B cells? Immunol. Res. 57: 361-369.
42. Johnson, S.A. & J.C. Cambier. 2004. Ageing, autoimmunity and arthritis: senescence of the B cell compartment-implications for humoral immunity. Arthritis Res. Ther. 6: 131-139.
43. Kline, G.H. et al. 1999. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol. 162: 3342-3349.
44. Keren, Z. et al. 2011. B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging. Blood 117: 3104-3112.
45. Melamed, D. & D.W. Scott. 2012. Aging and neoteny in the B lineage. Blood 120: 4143-4149.
46. Klinman, N.R. & G.H. Kline. 1997. The B-cell biology of aging. Immunol. Rev. 160: 103-114.
47. Weksler, M.E. 2000. Changes in the B-cell repertoire with age. Vaccine 18: 1624-1628.
48. Johnson, S.A. et al. 2002. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J. Immunol. 168: 5014-5023.
49. Cancro, M.P. 2005. B cells and aging: gauging the interplay of generative, selective, and homeostatic events. Immunol. Rev. 205: 48-59.
50. Birjandi, S.Z. et al. 2011. Alterations in marginal zone macrophages and marginal zone B cells in old mice. J. Immunol. 186: 3441-3451.
51. Wols, H.A. et al. 2010. Migration of immature and mature B cells in the aged microenvironment. Immunology 129: 278-290.
52. Hao, Y. et al. 2011. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118: 1294-1304.
53. Ratliff, M. et al. 2013. In senescence, age-associated B cells secrete TNFalpha and inhibit survival of B-cell precursors. Aging Cell 12: 303-311.
54. Zheng, B. et al. 1997. Immunosenescence and germinal center reaction. Immunol. Rev. 160: 63-77.
55. LeMaoult, J. et al. 1997. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol. Rev. 160: 115-126.
56. Lee, H. et al. 2010. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect. Dis. 10: 60.
57. Nicoletti, C. et al. 1991. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J. Immunol. 147: 2750-2755.
58. Yang, X. et al. 1994. Repertoire diversity of antibody response to bacterial antigens in aged mice. IV. Study of VH and VL gene utilization in splenic antibody foci by in situ hybridization. J. Immunol. 152: 2214-2221.
59. Haas, K.M. et al. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
60. Hardy, R.R. & K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
61. Ehrenstein, M.R. & C.A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
62. Berland, R. & H.H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
63. Briles, D.E. et al. 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156: 1177-1185.
64. Benedict, C.L. et al. 2000. Terminal deoxynucleotidyl transferase and repertoire development. Immunol. Rev. 175: 150-157.
65. Benedict, C.L. & J.F. Kearney. 1999. Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 10: 607-617.
66. Meroni, P.L. et al. 2004. Anti-beta 2 glycoprotein I antibodies in centenarians. Exp. Gerontol. 39: 1459-1465.
67. Shaw, P.X. et al. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
68. Binder, C.J. et al. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9: 736-743.
69. Lewis, M.J. et al. 2009. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120: 417-426.
70. -/- mice. Atherosclerosis 220: 59-65.
71. Hayakawa, K. et al. 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16: 1313-1316.
72. Lalor, P.A. et al. 1989. Feedback regulation of murine Ly-1 B cell development. Eur. J. Immunol. 19: 507-513.
73. Kantor, A.B. 1996. V-gene usage and N-region insertions in B-1a, B-1b and conventional B cells. Semin. Immunol. 8: 29-35.
74. + B1 cells containing abundant N-region additions. Eur. J. Immunol. 39: 2383-2394.
75. Duber, S. et al. 2009. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114: 4960-4967.
76. Esplin, B.L. et al. 2009. A differentiation pathway for B1 cells in adult bone marrow. Proc. Natl. Acad. Sci. U.S.A. 106: 5773-5778.
77. Gregoire, K.E. et al. 1979. Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse. J. Immunol. 123: 1347-1352.
78. Holodick, N.E. et al. 2014. B-1a cell diversity: nontemplated addition in B-1a cell Ig is determined by progenitor population and developmental location. J. Immunol. 192: 2432-2441.
79. Ghosn, E.E. et al. 2012. Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 109: 5394-5398.
80. Barber, C.L. et al. 2011. Reduced production of B-1-specified common lymphoid progenitors results in diminished potential of adult marrow to generate B-1 cells. Proc. Natl. Acad. Sci. U.S.A. 108: 13700-13704.
81. Montecino-Rodriguez, E. & K. Dorshkind. 2012. B-1 B cell development in the fetus and adult. Immunity 36: 13-21.
82. Stall, A.M. et al. 1988. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc. Natl. Acad. Sci. U.S.A. 85: 7312-7316.
83. Herzenberg, L.A. et al. 2000. B-1 cell origins and VH repertoire determination. Curr. Top. Microbiol. Immunol. 252: 3-13.
84. Gu, H. et al. 1990. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J. 9: 2133-2140.
85. Alter-Wolf, S. et al. 2009. Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage. Mech. Ageing Dev. 130: 401-408.
86. Rothstein, T.L. et al. 2013. Human B-1 cells take the stage. Ann. N.Y. Acad. Sci. 1285: 97-114.
87. Holodick, N.E. et al. 2010. Immunoglobulin secretion by B1 cells: Differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur. J. Immunol. 40: 3007-3016.
88. Yang, Y. et al. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. U.S.A. 104: 4542-4546.
89. Holodick, N.E. et al. 2014. Splenic B-1a cells expressing CD138 spontaneously secrete large amounts of immunoglobulin in naive mice. Front. Immunol. 5: 129.
90. Murray, C.J. & A.D. Lopez. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276.
91. Weksler, M.E. et al. 2009. Immune therapy for age-related diseases. Trends Immunol. 30: 344-350.
92. Yoshimoto, M. et al. 2011. Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc. Natl. Acad. Sci. U.S.A. 108: 1468-1473.